Links
HEOR in 2020: Gazing into the crystal ball. Self-assessed unmet need. Hospital consolidation and patient satisfaction. Which countries oppose WHO drug price transparency proposals? Is bundled payment the future?
Unbiased Analysis of Today's Healthcare Issues
HEOR in 2020: Gazing into the crystal ball. Self-assessed unmet need. Hospital consolidation and patient satisfaction. Which countries oppose WHO drug price transparency proposals? Is bundled payment the future?
Guest post by Mark Linthicum, Director of Scientific Communications at The Innovation and Value Initiative To get to Value Assessment 2.0, a concerted effort across fields of expertise is needed to improve methods and establish practical approaches that make sense in real-world decision making. The Innovation and Value Initiative’s Open-Source Value Project aims to catalyze…
At the American Psychiatric Association meeting last week, the APAM Center provided some suggestions. AJMC reports that their 5 policy recommendations include: Create action plan to insure network adequacy. “Employers can start by expanding services at the inpatient and outpatient levels, and engaging regional and national organizations to add providers, including specialty providers. They can…
This question is difficult to answer. In many countries with government provided health care, wait times are long. For the Veterans Affairs (VA) beneficiaries, this does not seem to be much of an issue according to a Penn et al. (2019) study covering wait times between 2014 and 2019: Although wait times in the VA…
Will mHealth save the NHS? Altruism and physician specialty choice. Children’s access to cancer drugs is >6 years behind adults. Interview with Ezekiel Emanual. Do economists need data visualizations?
Below are two posters I am presenting at the 2019 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting. The first poster I presented today, the second poster below I will be presenting tomorrow, May 21, between 6-7pm CDT. HOW MUCH DO INDIVIDUALS VALUE ACCESS TO INNOVATIVE LUNG CANCER THERAPIES? A STATED PREFERENCE SURVEY…
The 2019 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting has kicked off in New Orleans. One interesting Panel that I am moderating is titled “How much should we – and can we- pay for gene therapies?” I am serving as the moderator and the panelists on this issue panel include: Anupam B.…
Check-out your reading list for the weekend: Mental health services after incarceration. Netflix and pills. The physician’s view on workers comp. Provider consolidation in New England. Should we subsidize telecare services?
Perhaps according to Austin Frakt. He writes in JAMA Forum: In every year since 2011, more hospitals have closed than opened…For example, 15 of the 21 hospitals that closed in 2016 were in rural communities, and since 2010, nearly 90 rural hospitals have done so. Hundreds more are at risk of closure.One source of financial challenges to…
While I leave the answer to the first question for another day, the answer to the second question is ‘yes’. Done, Herring and Wu (2019) explain’s Maryland’s approach to global capitation payments for hospitals covering both inpatient and outpatient hospital services. Maryland is the only state that still operates an all‐payer rate‐setting system for hospitals,…